SSY Group Debuts at 2026 South Africa International Food & Food Processing Exhibition

Local time June 10, the 2026 South Africa International Food & Food Processing Exhibition grandly opened at Cape Town International Convention Centre. The international trade team of SSY Group attended the show with bulk and specialty raw material products to actively explore the African market.

Running for three days, this influential professional trade event for food and beverages in Africa serves as a key platform for releasing industrial trends, technical exchanges and product displays. It also acts as a vital bridge connecting global suppliers with local African buyers.

At the booth, the Group’s foreign trade team received new and existing international clients with professionalism and enthusiasm. The team highlighted core competitive products manufactured by its subsidiaries Guangxiang Pharmaceutical and Guolong Pharmaceutical, including caffeine, azithromycin, theophylline and metronidazole. Staff elaborated on the Group’s eco-friendly production model and advanced manufacturing technologies, and held in-depth negotiations on potential cooperation in 2026. The comprehensive product portfolio drew crowds of local African purchasers, as well as clients from Europe and other emerging markets.

In recent years, aligned with domestic market demand, the Group has implemented an integrated development strategy covering both APIs and finished preparations. It accelerates the R&D of specialty APIs and extends its innovative API chain to mid-to-high-end segments. At present, the Group boasts 102 bulk and specialty API varieties with an expanding product lineup sold to dozens of countries and regions worldwide. In 2025, its flagship product caffeine obtained the European Pharmacopoeia Certificate of Suitability (CEP), further elevating the Group’s global reputation.

“The African market represents a critical growth engine within the global pharmaceutical supply chain, and we have full confidence in its enormous potential,” said the Group’s foreign trade director. The South African exhibition not only provides a stage to showcase our products, but also lays a solid brand foundation and raises brand recognition across Africa.

Taking its competitive product lines as a starting point, SSY Group will steadily build a diversified global sales network. Leveraging various international expos, the company will gain deeper insights into overseas market demands and foster international partnerships to facilitate smooth domestic and international dual circulation. It will further develop market-specific products and cooperation channels, striving to ship more high-quality “Made by SSY Group” pharmaceutical products across the globe.